Annals of the Rheumatic Diseases

📰NEWS ALERT! The Annals of the Rheumatic Diseases confirms its status as top-ranking journal in rheumatology.

📖 Read the #eularPressRelease 👉https://pulse.ly/ijbhsjenog

🙌Thank you for attending the #EULAR2025 Congress!
We hope you had a memorable experience!

📺Access the On-demand Congress Platform until 31 December 2025 👉 https://pulse.ly/vl0sg17x4k

✈️We Look forward to seeing you at #EULAR2026 in London!

#EULAR #EULAR2025 #Rheumatology

#EULAR2025 Pearls of wisdom from the difficult cases of #SLE #pregnancy 🤰🦋
🟢pre-pregnancy multidisciplinary risk stratification
🟠tailored treatment and monitoring
🟣compatibility of drugs
🟤T2T strategy: reduce & discontinue steroids
🔵shared-decision should be guided by benefit-risk assessment

🎤 Ricardo J. O. Ferreira presented the HPR highlights during the closing plenary session of #EULAR2025.
A great way to reflect on key advances, inspiring talks and shared perspectives from the HPR community.
posted by thomasdavergne.bsky.social

💥 The 3 “Move Together” sessions were a great success at #EULAR2025!
Hands-on, inclusive, and packed with practical tools to bring exercise science into daily care for people with RMDs.
A huge thank you to all who joined us!
posted by thomasdavergne.bsky.social

Highlights #EULAR2025 from the PARE Sessions by Michael Poelzi :
🔹 Digital tools are promising
🔹 Co-creation, inclusion, and safe care spaces are essential
🔹 Pain, fatigue, sexual and mental health must be seen
🔹 Communication is everything.
#HealthEquity #DigitalHealth
IH

🎯 At #EULAR2025, Rafael Prieto Moreno reminded us:
✔️ Accessibility of digital health is good, but not perfect
✔️ Co-creation must be context-adapted
✔️ Equity must be designed—not assumed
A strong case for inclusive digital rehab tools.
posted by thomasdavergne.bsky.social

📊 At #EULAR2025, Loreto Carmona illustrated how social determinants shape RA outcomes in Spain — through the compelling case of a woman living with RA.
A powerful reminder that health inequalities are lived realities.
posted by thomasdavergne.bsky.social

🧪 Late-breaking APEX trial results!
In active PsA pts (≥3 TJC/SJC, CRP ≥0.3, erosions on X-ray), GUS Q4W & Q8W 🆚 PBO showed:
🦴 Less radiographic progression at W24 (vdH-S: 0.55/0.54 vs 1.35; P=0.002/<0.001)
💪 Higher ACR20 responses
#EULAR2025
Posted by @jgletarouilly.bsky.social

After GRAPPA, it's time for EULAR to its points to consider and definitions of difficult-to-manage and treatment-refractory PsA

#EULAR2025
Posted by @jgletarouilly.bsky.social

👏 This morning at #EULAR2025, Lucy Brading shared the co-design process behind D-MAPP — a digital self-management app for distal upper limb MSDs.
A great example of meaningful patient involvement from day one.
posted by thomasdavergne.bsky.social

Health literacy isn’t about “high” or “low”, it’s about challenges, needs, and diversity.
Powerful reminder from Mark Bakker at today’s #EULAR2025 session on health literacy in rheumatology.
#Rheumatology #HealthEquity
IH

📚 Jet Veldhuijzen van Zanten presented the updated EULAR recommendations on patient education for people with inflammatory arthritis at #EULAR2025.
A key milestone for HPRs 👩‍⚕️👨‍⚕️
The full publication will be available soon.
posted by thomasdavergne.bsky.social

🚺 #EULAR2025 RMD & #Menopause: is there a place for HRT? YES!
🟪 In perimenopausal women with RMD, let's consider the role of hormonal changes in the fluctuations of symptoms.
🟪 Individualized approach is the key
🟪 Benefits of HRT may outweigh the slighty increased risks in most women
#reprohealth

🧬 Does MTX with 1st ADA shot prevent anti-ADA antibodies in axSpA?
🇫🇷 MESYNAD RCT: ❌ No difference at 6mo
💉 MTX+ADA = ADA alone
No added benefit for immunogenicity.
#EULAR2025 #POS0889
Posted by @jgletarouilly.bsky.social

📊 RABBIT-SpA registry insights:
🔹 8.5% met ASAS D2M axSpA criteria (75/881)
🔹 2.5% met TR criteria (22/881)
👩 D2M-axSpA patients = more female, less HLA-B27

Results similar to those from the Dutch cohort
#EULAR2025
Posted by @jgletarouilly.bsky.social

🧠✨GRAPPA Definitions

🔹Complex-to-Manage PsA (C2M PsA)
➡️ Persistent symptoms despite treatment with≥1 b/tsDMARD 💊

🔸 Difficult-to-Treat PsA (D2T PsA)
➡️ Characterized by failure to respond to ≥3 prior PsA therapies with different MoA 🔄💥

#EULAR2025
Posted by @jgletarouilly.bsky.social

Gaslighting and Unconscious Bias in Rheumatology , a powerful session at #EULAR2025 exposing the harm caused within and beyond clinical teams.

Disagree Well. Speak truth. Challenge bias.

#Gaslighting #UnconsciousBias #EULAR2025
IH

📲 Inspiring work from Deniz Bayraktar at #EULAR2025!
She adapted the SARAH self-rehab programme for people with RA in Türkiye — and delivered it via WhatsApp! 🇹🇷💬
A brilliant example of accessible care in action.

👥 Are you a health professional in rheumatology?
Join the LinkedIn group to connect, share & grow with the HPR community!
🔗 www.linkedin.com/groups/10072...

Let’s build bridges across borders 🌍
posted by thomasdavergne.bsky.social
#EULAR2025 #HPR

📢 Reminder at #EULAR2025
🧠 HPR Move Together: Moving Science into Practice
📍Walkway Hall 6 & 7 – Upper Floor

🗓️ June 12 | 12:15–13:15
🗓️ June 13 | 12:15–13:15
🗓️ June 14 | 10:30–11:30

Let’s move science into action!
posted by thomasdavergne.bsky.social

ARD across Social Media Channels

@nellziade.bsky.social

Hello from Day 2 of EULAR Congress!
Don’t miss Poster Tour 4 in 30 minutes – all about Clinical and Treatment Aspects of Spondyloarthritis.

#EULAR2025 #PosterTour #Spondyloarthritis
IH

🔬SPEED RCT in patients with PsA and poor prognostic factors

🎯 Primary Endpoint: Mean PASDAS at 24 weeks
✅ Combination csDMARDs** > Standard step-up
✅️TNFi** > Standard step-up
❌ No significant difference between Combination csDMARDs and TNFi

#EULAR2025
Posted by @jgletarouilly.bsky.social

📍Foot OA affects 1 in 6 adults >50 and is often disabling.
🩺 Clinical ID is easier for 1st MTP than midfoot OA.
💉 Hyaluronan no better than saline.
👟 Prefab orthoses = rocker soles (but better adherence).

Final take-home messages from Hylton Menz at #EULAR2025
posted by thomasdavergne.bsky.social

Get ready for #EULAR2025!

✨️ Select from 177 Scientific sessions

✨️ Enjoy interaction with 350 distinguished speakers

✨️ Check out the new session formats

✅️ Spotlight consultation
✅️ Rheumatology meets ...
✅️ Fishbowl sessions

There is something for everyone!

@eular.org

Good morning Barcelona! We are fully operational onsite at #EULAR2025 with an enthusiastic team of guest Social Media Editors.

👉🏻Follow along for live updates!

Make the most of #EULAR2025 with the official Congress App!

🗺️ Navigate the 4-day event with ease, find session info, symposia, exhibition highlights, and venue services.
🗓️ Build your personal schedule
📱Download the EULAR 2025 Congress App and elevate your experience!

#rheumatology

📢 Welcome to the ARD BlueSky
Channel!

👉🏻 Follow along for the latest updates on published articles and more!

🎤 Stay tuned also for live coverage from #EULAR2025 Congress taking place in Barcelona on 11-14 June 2025.

📖 Browse the journal at www.sciencedirect.com/journal/anna...